Get the Stockscreener App
11.00
2.71%
+0.29
After Hours:
11.00
Treace Medical Concepts Inc stock is currently priced at $11.00, with a 24-hour trading volume of 439.18K.
It has seen a +2.71% increased in the last 24 hours and a -10.28% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $10.77 pivot point. If it approaches the $11.20 resistance level, significant changes may occur.
Previous Close:
$10.71
Open:
$11
24h Volume:
439.18K
Market Cap:
$681.30M
Revenue:
$187.12M
Net Income/Loss:
$-49.53M
P/E Ratio:
-15.07
EPS:
-0.73
Net Cash Flow:
$-46.03M
1W Performance:
+5.77%
1M Performance:
-10.28%
6M Performance:
-0.36%
1Y Performance:
-57.36%
1D Range:
$10.82
$11.24
52W Range:
$5.27
$27.70
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
904 373 5940
Address
203 Fort Wade Road, Suite 150, Ponte Vedra
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research
Treace to Present at Bank of America Health Care Conference
GlobeNewswire Inc.
Treace Announces First Annual National Bunion Day
GlobeNewswire Inc.
Treace to Report First Quarter 2024 Financial Results
GlobeNewswire Inc.
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
GlobeNewswire Inc.
Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Treace Medical Concepts Inc (TMCI) Revenue 2024
TMCI reported a revenue (TTM) of $187.12 million for the quarter ending December 31, 2023, a +31.92% rise year-over-year.
Treace Medical Concepts Inc (TMCI) Net Income 2024
TMCI net income (TTM) was -$49.53 million for the quarter ending December 31, 2023, a -15.68% decrease year-over-year.
Treace Medical Concepts Inc (TMCI) Cash Flow 2024
TMCI recorded a free cash flow (TTM) of -$46.03 million for the quarter ending December 31, 2023, a -1.20% decrease year-over-year.
Treace Medical Concepts Inc (TMCI) Earnings per Share 2024
TMCI earnings per share (TTM) was -$0.81 for the quarter ending December 31, 2023, a -5.19% decline year-over-year.
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.
0.77%
Cap:
|
Volume (24h):